Abstract
In this review we will briefly examine some physiological and pharmacological aspects of the dopaminergic and non-dopaminergic cells of the midbrain in relationship to pathological conditions such as extrapyramidal disorders, mental illness, drug seeking behaviour and epilepsy.
MeSH terms
-
Animals
-
Basal Ganglia Diseases / drug therapy
-
Basal Ganglia Diseases / pathology
-
Basal Ganglia Diseases / physiopathology
-
Dopamine / physiology*
-
Epilepsy / drug therapy
-
Epilepsy / pathology
-
Epilepsy / physiopathology
-
Humans
-
Mental Disorders / drug therapy
-
Mental Disorders / pathology
-
Mental Disorders / physiopathology
-
Parkinson Disease / drug therapy
-
Parkinson Disease / pathology
-
Parkinson Disease / physiopathology
-
Substance-Related Disorders / drug therapy
-
Substance-Related Disorders / pathology
-
Substance-Related Disorders / physiopathology
-
Substantia Nigra / drug effects
-
Substantia Nigra / pathology
-
Substantia Nigra / physiopathology*
-
Ventral Tegmental Area / drug effects
-
Ventral Tegmental Area / pathology
-
Ventral Tegmental Area / physiopathology*